Optum Infusion Services 308, LLC, Chandler, AZ

Is Optum Infusion Services 308, LLC registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does Optum Infusion Services 308, LLC hold a Arizona pharmacy license?

State board of pharmacy records for Arizona are not checked: the board’s website, which hosts its license verification and board orders, answers automated requests with a bot challenge, and this index does not work around blocks. The Texas State Board of Pharmacy also lists nonresident license 36192 for OPTUM INFUSION SERVICES 308, LLC, CHANDLER, AZ, status Active, as of Nov 15, 2026. The California State Board of Pharmacy also lists nonresident license NRP 3120 for Optum Infusion Services 308 Llc, Chandler, AZ, status Active and license NSC 102019 for Optum Infusion Services 308 Llc, Chandler, AZ, status Active, as of Nov 6, 2026. The Colorado State Board of Pharmacy also lists nonresident license OSP 7952 for Optum Infusion Services 308, LLC, Chandler, AZ, status Active, as of Nov 15, 2026. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054023564 for OPTUM INFUSION SERVICES 308 LLC, CHANDLER, AZ, status ACTIVE and license 054023392 for OPTUM INFUSION SERVICES 308 LLC, CHANDLER, AZ, status CHANGE OF OWNERSHIP, as of Nov 13, 2026. The Connecticut Department of Consumer Protection also lists nonresident license PCN.0004520 for OPTUM INFUSION SERVICES 308, LLC, CHANDLER, AZ, status ACTIVE (CURRENT), as of Nov 15, 2026. The Delaware Division of Professional Regulation also lists nonresident license A9-0013287 for Optum Infusion Services 308, LLC, CHANDLER, AZ, status Active, as of Nov 10, 2026. The Michigan Department of Licensing and Regulatory Affairs also lists nonresident license 5301013822 for Optum Infusion Services 308, LLC, Chandler, AZ, status Active, as of Nov 10, 2026.

Has Optum Infusion Services 308, LLC had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter (Dec 13, 2022) for Optum Infusion Services 308, LLC. State board of pharmacy records for Arizona are not checked: the board’s website, which hosts its license verification and board orders, answers automated requests with a bot challenge, and this index does not work around blocks.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
Optum Infusion Services 308, LLC
Location
Chandler, AZ
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
1
Warning letters on FDA’s actions page
1
Latest action on that page
Dec 13, 2022
FDA Data Dashboard inspections
No matching site found
Form 483 text on this page
1 Form 483, 6 observations
State board records
Not checked

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Optum Infusion Services 308, LLC, a 503A facility, with 2 dated actions.

Document
Dec 13, 2022Warning letterWarning Letter Issued 12/13/2022FDA copy (archived)
Mar 18, 2022Form 483483 issued 3/18/2022FDA copy (archived)

A Form 483 lists investigator observations, not a final FDA determination. A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own.

FDA inspection classifications and published Form 483s

No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483 for this site has 6 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it, with long ones cut and linked to the full form. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection Mar 8, 2022 to Mar 18, 2022: 6 observations

Firm on the cover
Optum Infusion Services 308, LLC, 2555 W Fairview St Ste 104 Bldg D, Chandler, AZ 85224 -4708
FEI number
3017600845
Establishment type on the cover
Producer of Sterile Drug Products
FDA district office on the cover
19701 Fairchild Irvine, CA 92612-2445
Matched to this page by
firm name, city and state on the cover; linked from actions page
FDA document
Read the full 483 (Internet Archive copy FDA links)

Observation 1

You did not make adequate product evaluation and take remedial action where actionable microbial contamination was found to be present in the ISO 5 classified aseptic processing area during aseptic production.

Specifically, your firm failed to evaluate the potential impact of sterile drug products produced in your cleanroom after positive microbiological growth (bacterial/fungal growth) was found in ISO-5 hoods.

A. EM/Microbiological growth excursion dated November 22, 2021: On 11/22/2021, your firm conducted <Redacted B4> environmental monitoring in ISO-5, ISO7, & ISO-8 areas and collected viable air and contact surface samples for testing. The EM samples were incubated, and growth (contact surface) was <Redacted B4> recovered from the keypad of a Repeater Pump <Redacted B4> located inside the ISO-5 (Hood <Redacted B4> ) and <Redacted B4> in IS0-7 <Redacted B4> room. The positive plates were shipped to <Redacted B4> for ID test and on 12/3/2021 you were informed the identity of the organisms were Brevivacterium species, Micrococcus species, and Coagulase Negative Staphylococcus. ...

Read the full 483 (Internet Archive copy FDA links)

Observation 2

Personnel touched equipment or other surfaces located outside of the ISO 5 classified aseptic processing area with gloved hands and then engaged in aseptic processing without changing or sanitizing gloves.

Specifically,

A. On 3/8/2022, a compounding technician was observed opening sterile bags <Redacted B4> in ISO-7 <Redacted B4> area then moving the bags into ISO-5 Laminar Air Flow Hood (Hood <Redacted B4> to make Rx# <Redacted B4> SMOFlipid 20% 500ml bag). The same technician was observed not sanitizing the gloved hands in ISO-7 environment before touching the DCA (Direct Compounding Area) inside the ISO-5 hood.

B. On 3/ 10/ 2022, two technicians were observed with hair not fully covered (hair sticking out on back of head) while they were performing <Redacted B4> cleaning in the ISO-7 <Redacted B4> room and ISO-5 hoods.

C. On 12/ 13/ 2021, video of <Redacted B4> cleaning was reviewed and I observed personnel storing sterile supplies (ex: sterile bags, tubes, syringes) in trash bags then placing the entire content of the trash bags (sterile supplies+ trash bags) into cleanroom trash bins. Sterile supplies are used to make drug sterile products in ISO-5 hoods.

D. ...

Read the full 483 (Internet Archive copy FDA links)

Observation 3

Personnel engaged in aseptic processing were observed with exposed hair.

Specifically, on 3/11/2022, two technicians were observed with facial hair (beard) protruding out of their masks while producing sterile drug products. One technician was observed standing in front of the ISO-5 Hood <Redacted B4> while producing Rx# <Redacted B4> (CeFAZolin 2gm in 20ml). The other technician was observed standing in front of the ISO-5 Hood <Redacted B4> while producing <Redacted B4> . Both sterile prescriptions listed above were released and distributed to patients.

Observation 4

The ISO 5 classified aseptic processing areas had particle-generating equipment or surface.

Specifically, your firm conducted <Redacted B4> certification of classified areas (ISO 5, ISO-7, & ISO ­8) including smoke studies then resumed sterile operations on the same day without cleaning. Video recording shows static and dynamic smoke studies were performed on all ISO-5 hoods (hood <Redacted B4>), Video recording also revealed actual drug products were used in dynamic smoke study for hood <Redacted B4>. Your firm failed to provide evidence showing that cleanroom areas and ISO-5 hoods were cleaned and disinfect after the certification process and smoke studies done on 4/16/2021. Prescription log shows that over sterile drug products were made and released for distribution to patients on 4/16/2021.

Observation 5

Vennin was observed in your production area.

Specifically, your firm failed to implement effective remediation plan and pest control program resulting in three incidents of pest/insects found in the classified areas (ISO-5, ISO-7, ISO-8) where sterile drug products are made:

• One live gnat landed inside of ISO-5 Laminar Air Flow Hood <Redacted B4> on 4/2/2021. Your firm failed to evaluate the potential impact to sterile drug products made in Hood <Redacted B4> on 4/2/2021.

• One live crane fly found in <Redacted B4> room (ISO-7) on 3/10/2021. • One live fly found in the exit <Redacted B4> room (ISO-8) on 2/7/2022.

Observation 6

You had inadequate HEPA filter airflow over the area to which sterile product was exposed.

Specifically, the smoke study conducted under dynamic conditions for ISO-5 hoods (hoods <Redacted B4>, <Redacted B4> performed on April 16, 2021 does not represent your actual work conditions of making sterile drug products and did not show the various techniques or equipment set in normal operations. For example the sterile drug production of TPN (Total Parenteral Nutrient) products using the Repeater Pump and <Redacted B4> equipment/machines.

State board of pharmacy records

State board of pharmacy records for Arizona are not checked: the board’s website, which hosts its license verification and board orders, answers automated requests with a bot challenge, and this index does not work around blocks.

Nonresident licenses in other states

These boards list a nonresident license whose record names this pharmacy’s own name, city and state.

Texas State Board of Pharmacy, file dated Nov 15, 2026 (Texas).

LicenseType as the board gives itName on the board recordLocationStatusPrior disciplinary orders (file flag)
36192Non Resident Sterile CompoundingOPTUM INFUSION SERVICES 308, LLCCHANDLER, AZActiveNo

California State Board of Pharmacy, file dated Nov 6, 2026 (California).

LicenseType as the board gives itName on the board recordLocationStatus
NRP 3120Non Resident PharmacyOptum Infusion Services 308 LlcChandler, AZActive
NSC 102019Non Resident Licensed Sterile CompoundingOptum Infusion Services 308 LlcChandler, AZActive

Colorado State Board of Pharmacy, file dated Nov 15, 2026 (Colorado).

LicenseType as the board gives itName on the board recordLocationStatus
OSP 7952OSPOptum Infusion Services 308, LLCChandler, AZActive

Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).

LicenseType as the board gives itName on the board recordLocationStatus
054023564LICENSED PHARMACYOPTUM INFUSION SERVICES 308 LLCCHANDLER, AZACTIVE
054023392LICENSED PHARMACYOPTUM INFUSION SERVICES 308 LLCCHANDLER, AZCHANGE OF OWNERSHIP

Connecticut Department of Consumer Protection, file dated Nov 15, 2026 (Connecticut).

LicenseType as the board gives itName on the board recordLocationStatus
PCN.0004520NONRESIDENT PHARMACYOPTUM INFUSION SERVICES 308, LLCCHANDLER, AZACTIVE (CURRENT)

Delaware Division of Professional Regulation, file dated Nov 10, 2026 (Delaware).

LicenseType as the board gives itName on the board recordLocationStatus
A9-0013287Non Resident PharmacyOptum Infusion Services 308, LLCCHANDLER, AZActive

Michigan Department of Licensing and Regulatory Affairs, file dated Nov 10, 2026 (Michigan).

LicenseType as the board gives itName on the board recordLocationStatus
5301013822PharmacyOptum Infusion Services 308, LLCChandler, AZActive

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.